Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
30 25 Search
2025
Pemigatinib suppresses liver fibrosis and subsequent osteodystrophy in mice
Hepatology Communications
2025
Identification of pivotal genes and crucial pathways in liver fibrosis through WGCNA analysis
Technology and Health Care
2024
Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis
Journal of Nanobiotechnology
2024
PCPE-2 (procollagen C-proteinase enhancer-2): The non-identical twin of PCPE-1
Matrix Biology
2024
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis
Genes & Cancer
2024
Study on the molecular mechanism of dihydromyricetin in alleviating liver cirrhosis based on network pharmacology
Chemical Biology & Drug Design
2024
Current strategies for nonalcoholic fatty liver disease treatment (Review)
International Journal of Molecular Medicine
2024
HIF‑1 and macrophage activation signalling pathways are potential biomarkers of invasive aspergillosis
Experimental and Therapeutic Medicine
2023
The Dual Therapeutic Potential of Ottelione A on Carbon Tetrachloride-induced Hepatic Toxicity in Mice
Applied Biochemistry and Biotechnology
2023
EMP1 as a Potential Biomarker in Liver Fibrosis: A Bioinformatics Analysis
Gastroenterology Research and Practice
2022
Advances in Experimental Medicine and Biology
2022
Ivermectin Attenuates CCl4-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation
International Journal of Molecular Sciences
2022
Application of alkaline phosphatase‑to‑platelet ratio as a novel noninvasive index predicts liver fibrosis in patients with chronic hepatitis B
Experimental and Therapeutic Medicine
2022
Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary Fibrosis
Advances in Wound Care
2022
JAM‐A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence
Liver International
2022
Lipoxygenases in chronic liver diseases: current insights and future perspectives
Trends in Pharmacological Sciences
2022
Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer’s Disease
Oxidative Medicine and Cellular Longevity
2021
Identifying potential biomarkers in hepatitis B virus infection and its response to the antiviral therapy by integrated bioinformatic analysis
Journal of Cellular and Molecular Medicine
2021
Anti‑malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer
Oncology Letters
2021
Assessment of fibrotic pathways induced by environmental chemicals using 3D-human liver microtissue model
Environmental Research
2021
Germacrone improves liver fibrosis by regulating the PI3K/AKT/mTOR signalling pathway
Cell Biology International
2021
Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals
International Journal of Molecular Sciences
2020
Loss of hepatocyte cell division leads to liver inflammation and fibrosis
PLOS Genetics
2020
Extracellular Vesicles From Hepatocytes Are Therapeutic for Toxin-Mediated Fibrosis and Gene Expression in the Liver
Frontiers in Cell and Developmental Biology
2019
CELLULAR AND MOLECULAR MECHANISMS OF LIVER FIBROGENESIS
Hepatology and Gastroenterology
2019
Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease
Genes
2019
A Network Pharmacology Approach to Uncover the Molecular Targets and Associated Potential Pathways of Lycii Fructus for the Treatment of Retinitis Pigmentosa
Digital Chinese Medicine
Additional cited-by details will be shown when available from Crossref